SANTA BARBARA, Calif. — Sovato, a healthcare technology company enabling the implementation and scaling of remote robotic surgery and procedure programs, announced the closing of its Series B financing round, bringing total funding to $41 million. The investment will accelerate the development of Sovato’s first-of-its-kind platform, which empowers healthcare organizations to safely extend surgical expertise across any distance.
The funding round was led by growth-stage venture capital firm Beringea, with significant follow-on investments from existing backers. Notable participants included founding investor Polaris Partners, Intuitive, GS Ventures, Laerdal Million Lives Fund, Puma Venture Capital, Teladoc Health, and other private investors. The proceeds will support continued platform innovation and the expansion of Sovato’s strategic partnerships with surgical robotics companies, healthcare providers, and ecosystem collaborators.
“With this Series B funding and three years of proven momentum, Sovato is well-positioned to scale the only platform creating the market for remote surgery and procedure programs,” said Michael Gross, Managing Partner at Beringea and Sovato board director. “Co-Founders Dr. Yulun Wang, whose innovations have shaped the surgical robotics industry, and Cynthia Perazzo, along with the entire Sovato team, bring the leadership and bold vision to redefine surgical access and healthcare economics.”
“Over half the world’s population lacks access to timely, safe surgical care, and in the U.S., millions are still forced to travel for routine procedures—a challenge that will only grow as surgeon shortages intensify,” said Cynthia Perazzo, Co-Founder and CEO of Sovato. “Remote robotic surgery and procedure programs provide healthcare organizations with a practical way to extend the reach and impact of skilled surgeons, care teams, and operating rooms—enabling a more sustainable and accessible model of care.”
As the global robotic surgery market continues to expand—projected to grow 12.4 percent annually through 2030—Sovato’s system-agnostic platform offers healthcare providers a unique advantage. The platform can remote-enable any surgical, interventional, or diagnostic robotic system, allowing physicians to perform procedures safely and efficiently from distant locations.
Sovato has already integrated its technology with leading robotic systems, demonstrating safety and feasibility in preclinical cases conducted over distances ranging from hundreds to thousands of miles, both in the United States and abroad. These cases validate the platform’s ability to extend surgical expertise through a scalable hub-and-spoke model.
In collaboration with healthcare leaders and robotics organizations, Sovato is also helping to establish the clinical, operational, and technical standards necessary for safe and widespread adoption of remote robotic surgery and procedure programs worldwide.
